- Open Access
Revealing the evolution of the tumor immune microenvironment in follicular lymphoma patients progressing within 24 months using single-cell imaging mass cytometry
Journal of Hematology & Oncology volume 15, Article number: 115 (2022)
Patients with follicular lymphoma (FL) who experience disease progression within 24 months (POD24) have inferior outcomes. The tumor immune microenvironment (TIME) plays a crucial role in pathogenesis and progression of follicular lymphoma (FL). However, TIME evolution during progression of disease within 24 months (POD24) is elusive.
Spatially resolved and single-cell image mass cytometry with a panel of 36 metal-tagged antibodies was used to quantitatively analyze the TIME structure in 13 paired FLs at diagnosis and POD24.
Follicles and peri-follicular regions were well dissected in structure. Peri-follicular regions represented a barrier for immune infiltration into the follicles. More FL-cells in the peri-follicular regions suffered CD8+T cells attacks under simultaneous protection of regulatory T cells (Tregs) and/or macrophages compared with that in the follicles irrespective of POD24. During POD24, increased CD163− macrophages with PD-1 ligand upregulation and decreased CD8+T cells with upregulated LAG-3 expression around FL-cells were observed in the follicles. Spatial analyses demonstrated that FL-cells interacted more intimately with macrophages than with Tregs and less with cytotoxic T cells in both peri-follicular regions and follicles during POD24. In comparison, macrophages also cooperated more frequently with Tregs to simultaneously hijack FL-cells, creating an enhanced immunosuppressive environment in both peri-follicular and follicular regions during POD24.
Peri-follicular regions function as a barrier by recruiting both CD8+T cells and immunosuppressive cells, protecting follicular FL-cells from immune attack at diagnosis or POD24. FL-cells reside in a more immune-compromised microenvironment and evade immune cell attacks during POD24. Novel immunotherapeutic approaches harnessing LAG-3, macrophages, and Tregs will be empowered to overcome poor outcomes in patients with FL POD24.
Patients with follicular lymphoma (FL) who experience disease progression within 24 months (POD24) have inferior outcomes [1, 2]. Current biological understanding of POD24 is mainly based on alterations acquired at the time of diagnosis of FL , including gene-mutation-based prognostic model POD24-PI  and TIME-based model BioFLIPI , but biological studies on POD24 stages are rare. TIME played an important role in the progression of FL [3, 5, 6]. However, due to the lack of technologies that enable comprehensive spatial analysis at single-cell resolution with high-throughput phenotypic information, the evolution of TIME over the course of POD24 remains elusive.
Imaging mass cytometry (IMC) is a novo technology which enables the simultaneous spatial and phenotypic evaluation of up to 50 biomarkers from tissue sections stained with metal-tagged antibodies at single-cell resolution [7, 8]. Therefore, we used IMC to analyze TIME evolution from diagnosis to POD24 using 36 metal-tagged antibodies in 13 FL patients. IMC clearly identified follicles, peri-follicular regions, and the boundary in-between according to CD21/SMA/vimentin expression (Fig. 1A). A total of 12 clusters were identified in the TIME (Fig. 1B, C). Not all cells in the TIME directly interacted with FL-cells due to spatial segmentation. Therefore, analysis of neighboring components around FL-cells could reflect more accurately the microenvironment that each FL-cell resides in than cellular components in the whole sections. Macrophages (Mφs) were most abundant immunosuppressive subpopulation, which were twice as numerous as regulatory T cells (Tregs) adjacent to FL-cells at diagnosis or at POD24 (Fig. 1D, E). Furthermore, among the components that surround FL-cells, the percentage of CD163−Mφs but not CD163+Mφs increased at POD24 (Fig. 1E, F). However, the frequencies of Tregs around FL-cells did not significantly change after POD24 (Fig. 1F). A decrease in CD8+ T cells around FL-cells after POD24 was observed (Fig. 1F). Further phenotypic analysis showed that CD163−Mφs around FL-cells displayed higher expression of PD-L1 and PD-L2 (Fig. 1G), while CD8+T cells neighboring FL-cells showed higher expression of lymphocyte activation gene 3 but not programmed cell death protein 1(PD-1) after POD24 (Fig. 1H). However, when comparing intra-follicular TIME at diagnosis in patients with and without POD24, immune components around FL-cells were similar between two groups (Additional file 1: Fig. S1A). Imbalanced evolution in CD163−Mφs and CD8+ T cells surrounding FL-cells might result in a more immunosuppressive TIME after POD24.
Although the dynamic variations of FL-cells indicate the presence of immunosuppressive TIME after POD24, the evolution of spatial interactions between FL-cells and the immune cells is unknown. Eight interaction patterns were identified based on the colocalization of FL-cells with Mφs, Tregs, and CD8+T cells (Fig. 2A). Besides more exclusive interaction with Mφs in the follicular and peri-follicular regions (Pattern 4, Fig. 2B, F), more FL-cells simultaneously hijacked by Mφs and Tregs (Pattern 7) were observed in the follicles after POD24 (Fig. 2C). Furthermore, fewer FL-cells interacted with CD8+T cells (Pattern 2) without protection of immunosuppressive cells like Mφs or Tregs (Fig. 2D, E). Intriguingly, we found that peri-follicular regions represented a barrier for immune infiltration into the follicles. FL-cells in follicles were found to interact more with themselves (Additional file 1 Fig. S2A,B) and separated spatially from the attack by CD8+T cells than that in the peri-follicular regions. In contrast, FL-cells in the peri-follicular regions suffered more CD8+T cells attacks than in the follicles (Additional file 1: Fig. S2F). Notably, more FL-cells that interacted with CD8+T cells in the peri-follicular regions were simultaneously protected by Tregs and/or Mφs than in the follicles (Additional file 1: Fig. S2C). Even FL-cells distant from CD8+T cells in the outer areas were protected more frequently by the cooperation of Tregs and Mφs compared with that in the central regions (Additional file 1: Fig. S2C). Moreover, the barrier functions of peri-follicular regions were not changed after POD24 (Additional file 1: Fig. S2D, E).
In summary, IMC was applied to create a spatially preserved single-cell-resolution immune atlas from peri-follicular to follicular regions of FL, providing novel and significant insights of TIME evolution during POD24. An enhanced immunosuppressive TIME was emerged during POD24, characterized by increased TAMs and fewer CD8+T cells, higher expression of LAG-3 around FL-cells as well as more cooperation with Tregs and TAMs around the FL-cells. Consequently, new therapeutic approaches by modulating LAG-3, TAMs, or Tregs could potentially improve dismal survival in patients with POD24.
Availability of data and materials
The original contributions presented in the study are included in the article/supplementary materials. The IMC data will be uploaded in the public repository “Zenodo”.
Follicular dendritic cells
Fibrotic reticular cells
Inducible T cell costimulator
Imaging mass cytometry
Lymphocyte activation gene 3
Programmed cell death protein 1
Programmed cell death protein ligand 1
Programmed cell death protein ligand 2
Progression of disease with 24 months
Regions of interest
Smooth muscle alpha actin
Conventional CD4+ T cells
Follicular helper T cells
T cell immunoglobulin and mucin domain 3
Tumor immune microenvironment
Regulatory T cells
Zha J, Fan L, Yi S, Yu H, Zheng Z, Xu W, et al. Clinical features and outcomes of 1845 patients with follicular lymphoma: a real-world multicenter experience in China. J Hematol Oncol. 2021;14(1):131.
Casulo C, Dixon JG, Le-Rademacher J, Hoster E, Hochster HS, Hiddemann W, et al. Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials. Blood. 2022;139(11):1684–93.
Tobin JWD, Keane C, Gunawardana J, Mollee P, Birch S, Hoang T, et al. Progression of disease within 24 months in follicular lymphoma is associated with reduced intratumoral immune infiltration. J Clin Oncol. 2019;37(34):3300–9.
Jurinovic V, Kridel R, Staiger AM, Szczepanowski M, Horn H, Dreyling MH, et al. Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy. Blood. 2016;128(8):1112–20.
Mondello P, Fama A, Larson MC, Feldman AL, Villasboas JC, Yang ZZ, et al. Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma. Blood Cancer J. 2021;11(7):130.
Yang ZZ, Kim HJ, Villasboas JC, Price-Troska T, Jalali S, Wu H, et al. Mass cytometry analysis reveals that specific intratumoral CD4(+) T cell subsets correlate with patient survival in follicular lymphoma. Cell Rep. 2019;26(8):2178-93.e3.
Schwabenland M, Salie H, Tanevski J, Killmer S, Lago MS, Schlaak AE, et al. Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions. Immunity. 2021;54(7):1594–610.
Jackson HW, Fischer JR, Zanotelli VRT, Ali HR, Mechera R, Soysal SD, et al. The single-cell pathology landscape of breast cancer. Nature. 2020;578(7796):615–20.
The authors thank the Department of Pathology of The First Affiliated Hospital of Xiamen University for their assistance in choosing ROIs.
This work was financially supported by the National Natural Science Foundation of China (82170180 granted to Bing Xu, 81800163 granted to Jie Zha, 81800196 and 81770161 granted to Zhiming Li, 81900164 granted to Long Liu, 82100204 granted to Xingxing Yu), the Natural Science Foundation of Fujian Province (2020J011246 granted to Bing Xu), the Xiamen Municipal Bureau of Science and Technology (3502Z20209003 granted to Bing Xu, 3502Z20209008 granted for Zhifeng Li), and the Lymphoma Research Fund of the Chinese Anti-Cancer Association (CORP-117 granted to Bing Xu).
Ethics approval and consent to participate
All samples were obtained after the patients provided informed consent. IRB approval for this study was granted by the Institutional Human Ethics Review Committee of the First Affiliated Hospital of Xiamen University and Sun Yat-sen University Cancer Center, in accordance with the Declaration of Helsinki.
Consent for publication
All authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Liu, L., Yu, X., Li, Z. et al. Revealing the evolution of the tumor immune microenvironment in follicular lymphoma patients progressing within 24 months using single-cell imaging mass cytometry. J Hematol Oncol 15, 115 (2022). https://doi.org/10.1186/s13045-022-01326-z
- Immune signature
- T cells